Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News

October 30, 2012
Stribild Is as Safe, Effective as Atripla, Even Among Less-Adherent
New research shows Stribild, a.k.a. the Quad, is as effective and safe as Atripla in those who don’t adhere perfectly to their regimens. 
October 29, 2012
New Highly Sensitive, Low-Cost HIV Test Gives Early, Naked Eye Results
English researchers have developed a groundbreaking new HIV test with manifold benefits that include results visible to the naked eye, a reduced “window period” after infection and a dramatically lowered cost that could greatly benefit developing nations. 
Antiretroviral Treatment Fails to Lower Anal Cancer Rates
Long-term antiretroviral treatment of HIV does not protect against anal cancer--a concern because of high rates of anal cancer among people living with HIV.
October 25, 2012
In Potential Vaccine Breakthrough, Antibody Response Outwits HIV
A new discovery could prove a major stepping-stone toward developing an effective HIV vaccine. In South Africa, two women’s immune systems reacted to changes in  HIV cells by producing potent “broadly neutralizing antibodies” that could kill 88 percent of HIV found throughout the world. 
Twice-Yearly Checkups May Be All That’s Needed to Control HIV
A recent study found that HIV-positive people with undetectable viral loads experience the same rates of virologic control whether they undergo checkups every three, four or six months.
October 24, 2012
Hep C Hospital Admissions Spike Fivefold; Those for HIV Drop by Half
Rates of hospital admissions for people living with the hepatitis C virus (HCV) increased fivefold during a 15-year period, while those for people with HIV have dropped nearly 50 percent during the same span.
October 23, 2012
Most Inmates Linked to HIV Care in Jail Drop Out Upon Release
Only 38 percent of those linked to HIV care while in jail maintain steady checkups after release.
New Case of Life-Threatening Meningitis Underscores Need for Vaccinations
The New York City Department of Health and Mental Hygiene has identified a new case of invasive Neisseria meningitidis infection among local men who have sex with men (MSM), bringing this year’s incidence to nine and the three-year total to 14 cases.
October 22, 2012
High Rates of HIV Med Prescribing Errors Among Hospitalized Patients
Mistakes are common when it comes to prescribing antiretrovirals to people living with HIV who have been hospitalized. 
October 19, 2012
Multivitamins: More Not Better When HIV Meds are Being Used
More is not better when it comes to multivitamins combined with antiretroviral therapy, according to new data published by the Journal of the American Medical Association (JAMA).  
October 18, 2012
New Pneumococcal Vaccine Recs for People Living with HIV
People living with HIV should receive two different vaccines to help prevent serious strep-related illness.
October 17, 2012
Hep Roundtable Issues 2012 Candidate Survey Report
The National Viral Hepatitis Roundtable has released a preliminary version of its 2012 Candidate Survey, detailing various Congressional candidates’ positions on viral hepatitis and health care issues. 
October 16, 2012
HIV Integrase Inhibitor Isentress Linked to CNS Problems
The integrase inhibitor Isentress may be associated with central nervous system  symptoms, particularly when used with tenofovir or a proton pump inhibitor. 
October 15, 2012
Obesity Linked to Chronic Non-AIDS Health Problems in HIV+ People
Many people living with HIV experience multiple health complications, or “multimorbidity,” as they age, which appears to be partly driven by the rising incidence of obesity, according to a new study published online ahead of print by the Journal of Acquired Immune Deficiency Syndromes (JAIDS).

October 11, 2012
Topical Version of CMV Drug Shows Promise for Pre-Cancerous HPV Genital Disease
An experimental cream containing a drug used to treat a serious eye infection in people with AIDS has shown potential as a therapy for pre-cancerous genital lesions, according to clinical trial results published online ahead of print by the journal AIDS.
October 10, 2012
HIV Therapy Helps Reduce Risk of Non-AIDS Illnesses
Though non-AIDS-related health complications are still common among people living with HIV, data from a Spanish cohort suggests that the incidence of these problems has dropped and that CD4 cell gains and viral load reductions associated with antiretroviral therapy use can be credited with reducing the risk.
October 08, 2012
Hep C Treatment Adherence Matters Among those Coinfected with HIV
Pegylated interferon and ribavirin treatment is rarely a pleasant experience, but the best chance of having to go through it only once for hepatitis C is to take the medications exactly as prescribed, according to new data involving individuals coinfected with HIV published in AIDS and Behavior and reported by aidsmap.
October 04, 2012
Cardiovascular Disease Risk Remains High in HIV Elite Controllers
More evidence that immune activation and inflammation are key drivers of the increased cardiovascular disease risk among people living with HIV: Elite controllers—a rare subset of HIV-positive individuals who maintain undetectable viral loads and high CD4 cell counts in the absence of antiretroviral therapy—have significant hardening of the arteries (atherosclerosis), according to the results of a study published online ahead of print by the journal AIDS.
Many Nutritional Supplements Make False Claims
Dozens of over-the-counter health supplements, including some used by people living with HIV, viral hepatitis and other chronic diseases, are illegally labeled and lack scientific evidence for their marketed claims, according to a report released October 2 by the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services.
Meningitis Vaccine Now Recommended for Certain HIV+ Gay Men in NYC
New York City HIV-positive men who have had intimate contact with other men under certain circumstances since the beginning of September 2012 should receive the meningococcal vaccine, according to a new recommendation from the NYC Department of Health and Mental Hygiene.

October 02, 2012
Many Health Benefits for Patients with Access to Their Medical Records
A “vast majority” of patients who have online access to their medical records “reported an increased sense of control, greater understanding of their medical issues, improved recall of their plans for care, and better preparation for future visits,” according to an informal study conducted by clinicians at three large primary care practices in the United States and reported in the October 2 issue of Annals of Internal Medicine.
October 01, 2012
Free HIV Treatment for All England Residents Now in Effect
HIV treatment is now officially free for all who need it in England, including undocumented migrants and non-United Kingdom citizens, according to legislation that went into effect October 1.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.